Author

Taixin Wang

Observed names: T. Wang, Ting Wang

Institution: Qilu Pharmaceutical Co., Ltd. (China)

Observed institutions: Shanghai University of Traditional Chinese Medicine, Beijing Dao Pei Hospital, Qilu Pharmaceutical Co., Ltd. (China), Hebei Yanda Ludaopei Hospital

ORCID: 0009-0003-4039-9255

Observed ORCID: 0009-0003-4039-9255

OpenAlex ID: A5016750306

Pharmacokinetics, Bioequivalence, and Safety Studies of Crisaborole Ointment in Healthy Chinese Subjects

2025 · Yanchao Wang, Xiaofei Zhao, et al. · Clinical Pharmacology in Drug Development · 3

Bioequivalence of Aripiprazole Oral Soluble Films and Orally Disintegrating Tablets in Healthy Participants: A Crossover Study

2025 · Ruoming Li, Shaojie Yang, et al. · Clinical and Translational Science · 2

Comprehensive bioinformatics analysis of integrator complex subunits: expression patterns, immune infiltration, and prognostic signature, validated through experimental approaches in hepatocellular carcinoma

2024 · Yifei Xu, Wenlian Liao, et al. · Discover Oncology · 2

P377: Genetic Characteristics and Cd7-car-t Therapy of Trad::myc Translocation Positive Acute Lymphoblastic Leukemia Patients

2022 · T. Wang, J. Ni, et al. · HemaSphere · 1

Pb1716 Clinical and Genetic Features and Prognosis Analysis of Patients With Recurrent Genetic Abnormality T(12;22) (p13;q12)

2019 · T. Wang, X. Ma, et al. · HemaSphere

Works count: 5

Citation count: 7

H-index: 2

I10-index: